» Articles » PMID: 24076602

Analysis of Immune-related Loci Identifies 48 New Susceptibility Variants for Multiple Sclerosis

Overview
Journal Nat Genet
Specialty Genetics
Date 2013 Oct 1
PMID 24076602
Citations 668
Authors
Affiliations
Soon will be listed here.
Abstract

Using the ImmunoChip custom genotyping array, we analyzed 14,498 subjects with multiple sclerosis and 24,091 healthy controls for 161,311 autosomal variants and identified 135 potentially associated regions (P < 1.0 × 10(-4)). In a replication phase, we combined these data with previous genome-wide association study (GWAS) data from an independent 14,802 subjects with multiple sclerosis and 26,703 healthy controls. In these 80,094 individuals of European ancestry, we identified 48 new susceptibility variants (P < 5.0 × 10(-8)), 3 of which we found after conditioning on previously identified variants. Thus, there are now 110 established multiple sclerosis risk variants at 103 discrete loci outside of the major histocompatibility complex. With high-resolution Bayesian fine mapping, we identified five regions where one variant accounted for more than 50% of the posterior probability of association. This study enhances the catalog of multiple sclerosis risk variants and illustrates the value of fine mapping in the resolution of GWAS signals.

Citing Articles

Machine Learning Methods for Classifying Multiple Sclerosis and Alzheimer's Disease Using Genomic Data.

Arnal Segura M, Bini G, Krithara A, Paliouras G, Tartaglia G Int J Mol Sci. 2025; 26(5).

PMID: 40076709 PMC: 11900513. DOI: 10.3390/ijms26052085.


Comprehensive causal analysis between autoimmune diseases and glioma: A Mendelian randomization study.

Deng N, Agila R, He Q, You C, Zheng S Medicine (Baltimore). 2025; 104(10):e41815.

PMID: 40068088 PMC: 11902947. DOI: 10.1097/MD.0000000000041815.


Comparing Alzheimer's genes in African, European, and Amerindian induced pluripotent stem cell-derived microglia.

Moura S, Nasciben L, Ramirez A, Coombs L, Rivero J, Van Booven D Alzheimers Dement. 2025; 21(2):e70031.

PMID: 40008916 PMC: 11863361. DOI: 10.1002/alz.70031.


SREBF1, a target gene of multiple sclerosis and coronary heart disease: based on mendelian randomization study.

Du L, Cui Y, Zhou Y, Kwaku O, Ding X, Zeng L Hereditas. 2025; 162(1):22.

PMID: 39953634 PMC: 11827142. DOI: 10.1186/s41065-025-00388-6.


Is DEXI a Multiple Sclerosis Susceptibility Gene?.

Eriksson A, Emini N, Harbo H, Berge T Int J Mol Sci. 2025; 26(3).

PMID: 39940946 PMC: 11818924. DOI: 10.3390/ijms26031175.


References
1.
Gregory A, Dendrou C, Attfield K, Haghikia A, Xifara D, Butter F . TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature. 2012; 488(7412):508-511. PMC: 4268493. DOI: 10.1038/nature11307. View

2.
Eyre S, Bowes J, Diogo D, Lee A, Barton A, Martin P . High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet. 2012; 44(12):1336-40. PMC: 3605761. DOI: 10.1038/ng.2462. View

3.
Maier L, Lowe C, Cooper J, Downes K, Anderson D, Severson C . IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet. 2009; 5(1):e1000322. PMC: 2602853. DOI: 10.1371/journal.pgen.1000322. View

4.
Hemminki K, Li X, Sundquist J, Hillert J, Sundquist K . Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions. Neurogenetics. 2008; 10(1):5-11. DOI: 10.1007/s10048-008-0156-y. View

5.
Browning B, Yu Z . Simultaneous genotype calling and haplotype phasing improves genotype accuracy and reduces false-positive associations for genome-wide association studies. Am J Hum Genet. 2009; 85(6):847-61. PMC: 2790566. DOI: 10.1016/j.ajhg.2009.11.004. View